IP Verse

Krka Tovarna Zdravil competitive analysis

Latest publications and patents of Krka Tovarna Zdravil New

Explore the latest publications and patents granted to Krka Tovarna Zdravil, showcasing their recent innovations and technological advancements.

Last updated on: Sep 23, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Krka Tovarna Zdravil

EP2588090
Nov 22, 2023Pharmaceutical Oral Dosage Forms Comprising Dabigatran Etexilate And Its Pharmaceutically Acceptable SaltsPatent Maintained As Amended
EP2585051
Apr 8, 2020Pharmaceutical Oral Dosage Forms Comprising Lercanidipine And Enalapril And Their Pharmaceutically Acceptable SaltsPatent Maintained As Amended

Latest patents of Krka Tovarna Zdravil opposed by its competitors

Explore Krka Tovarna Zdravil's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2588090
Nov 22, 2023Pharmaceutical Oral Dosage Forms Comprising Dabigatran Etexilate And Its Pharmaceutically Acceptable Salts3
EP2585051
Apr 8, 2020Pharmaceutical Oral Dosage Forms Comprising Lercanidipine And Enalapril And Their Pharmaceutically Acceptable Salts1

Latest PTAB cases involving Krka Tovarna Zdravil

Discover the latest PTAB cases involving Krka Tovarna Zdravil, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Krka Tovarna Zdravil with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
KRKA TOVARNA ZDRAVIL - 4 - - Non-Active
EDER3 - - - Highly Aggressive
GENERICS UK211 - - - Highly Aggressive
GEORG KALHAMMERSTEPHAN TEIPEL3 - - - Highly Aggressive